Raj Shetal M, Vasavada Abhay R, Johar S R Kaid, Vasavada Vaishali A, Vasavada Viraj A
Iladevi Cataract and IOL Research Centre, Raghudeep Eye Clinic, India.
Int J Biomed Sci. 2007 Dec;3(4):237-50.
Post-operative capsular opacification is a multifactorial physiological consequence of cataract surgery. Opacification involving the central posterior capsule has a significant impact on high and low contrast acuity and low contrast sensitivity. The assessment of Posterior Capsule Opacification (PCO) on cadaver eyes, experimental studies, culture models and in clinical studies has provided an understanding of its pathogenesis. The proliferation, migration and abnormal differentiation of residual lens epithelial cells and fibers in the capsular bag have been implicated in the pathogenesis of PCO. The incidence and severity of PCO correlates to the meticulous use of surgical techniques, IOL optic edge designs and IOL materials. This article summarizes the clinical studies with recommendations for retarding the development of central PCO. It discusses experiments with pharmacological agents broadly categorized as anti-inflammatory, immuno-modulating, antiproliferative, antiadhering, antitransdifferentiating agents for the prevention of PCO. These studies will remain critical for future endeavors undertaken for eradication of PCO.
术后囊膜混浊是白内障手术的一种多因素生理后果。涉及中央后囊膜的混浊对高对比度和低对比度视力以及低对比度敏感度有重大影响。在尸体眼、实验研究、培养模型及临床研究中对后囊膜混浊(PCO)的评估,已增进了对其发病机制的理解。囊袋内残留晶状体上皮细胞和纤维的增殖、迁移及异常分化与PCO的发病机制有关。PCO的发生率和严重程度与手术技术的精细使用、人工晶状体光学边缘设计及人工晶状体材料相关。本文总结了临床研究,并给出延缓中央PCO发展的建议。文中讨论了将药理制剂大致分为抗炎、免疫调节、抗增殖、抗粘连、抗转分化制剂以预防PCO的实验。这些研究对未来根除PCO的努力仍至关重要。